✦ LIBER ✦
First-line treatment of ovarian/tubal/peritoneal cancer FIGO stage IIB–IV with paclitaxel/carboplatin with or without epirubicin (TEC vs TC). A gynecologic cancer intergroup study of the NSGO, EORTC GCG, and NCIC CTG. Results on progression-free survival
✍ Scribed by G.B. KRISTENSEN; I. VERGOTE; G. STUART; J.M. Del CAMPO; J. KÆRN; M. BAEKELANDT; A.B. LOPEZ; H. HIRTE; E. AAVALL-LUNDQVIST; E. LORENZ; O. CERAR
- Book ID
- 109085404
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 27 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1048-891X
No coin nor oath required. For personal study only.